Stem Cell Therapy for Diabetes Mellitus: Recent Progress and Hurdles

Saleem, Mohammad and Sabir, Shakila and Akhtar, Muhammad Furqan and Zahid, Sara and Niazi, Sammia Gul and Naeem, Muhammad and Saleem, Uzma and Saleem, Ammara (2019) Stem Cell Therapy for Diabetes Mellitus: Recent Progress and Hurdles. Critical Reviews in Eukaryotic Gene Expression, 29 (5). pp. 471-482. ISSN 1045-4403

Text (Article) CRE-25723 (1).pdf - Published Version Restricted to Registered users only Download (1MB) | Request a copy

Abstract

Diabetes mellitus (DM) is a devastating metabolic syndrome. Currently, parenteral exogenous insulin is the only therapy available around the world to treat type 1 DM. However, it does not tightly regulate blood glucose levels that ultimately lead to long-term complications. The development of pancreatic transplantation gives some hope in the radical cure of diabetes. A limited number of donors and host immune rejection are two major drawbacks associated with pancreatic transplantation. Stem cells are distinctive cells that can differentiate into any other type of specialized cells. Embryonic stem cells have been studied extensively and proved successful in producing beta cells. The numerous kinds of stem cells, including embryonic stem cells, induced pluripotent stem cells, and adult stem cells, prove to be among the notable candidates to treat DM. However, all stem cell therapies have their own limitations. This review article focuses on the progress and limitations in stem cell research to treat DM.

Item Type:	Article
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Faculty of Pharmaceutical Sciences (FPS) > Riphah Institute of Pharmaceutical Sciences Lahore
Depositing User:	Dr. Muhammad Furqan Akhtar
Date Deposited:	06 Jun 2020 08:16
Last Modified:	06 Jun 2020 08:16
URI:	http://research.riphah.edu.pk/id/eprint/353

Actions (login required)

View Item